The presence of cerebral oxidative stress in neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease has been demonstrated [48, 49], and CPZ interferes with the brain antioxidant system and causes oxidative stress in the corpus callosum. This evidence concerns the gene CPZ and Parkinson disease.